James Zucherman, MD
Orthopaedic Surgery of the Spine · San Francisco, CANPI 1194887760
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,610 of the $6,364 with a category attached, or 72.4%. 13 manufacturers reported payments, led by Benvenue Medical Inc at 43.5% of the total. Reporting peaked in 2019 at $3,231 and has fallen 93.9% since, to $197 in 2024. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in CA, where the typical reported total is $17,657.
Across 60 payments — averaging $106.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Benvenue Medical Inc$3K
- Medacta USA, Inc.$1K
- Relievant Medsystems, Inc.$867
- Stryker$751
- Spineart USA Inc$554
- Vertiflex, Inc.$147
- plus $228 from 7 others
Across 20 payments — averaging $3041.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Premia Spine, Ltd.$61K
What the payments were for
- Consulting fees$80013%
- Travel & lodging$95415%
- Food & beverage$4,61072%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Benvenue Medical Inc | 3 | $2,766 |
| Medacta USA, Inc. | 7 | $1,050 |
| Relievant Medsystems, Inc. | 4 | $867 |
| Stryker | 29 | $751 |
| Spineart USA Inc | 5 | $554 |
| Vertiflex, Inc. | 2 | $147 |
| Amgen | 2 | $56 |
| Titan Spine, LLC | 1 | $44 |
| Si-bone, Inc. | 3 | $39 |
| Medtronic | 1 | $26 |
| Davol Inc. | 1 | $24 |
| Orthofix Medical, Inc. | 1 | $21 |
| Baudax Bio Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kiva VCF Treatment System$2,751
- Blazer Vertebral Augmentation Kit$2,751
- Intracept$1,600
- MYSPINE$954
- Perla TL$487
- MAKO$157
- Superion ISS$130
How this compares
$6,364 in reported general payments places this provider in the 35th percentile of 288 orthopaedic surgery of the spine providers in California.
See all orthopaedic surgery of the spine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 22 | $316 |
| Methylprednisolone | 33 | $179 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in San Francisco
- Rayshad OshtorySan Francisco$593K
- Hyun BaeSanta Monica$56.8M
- Choll KimSan Diego$4M
- Stacey BedermanOrange$3.7M
- Gregory Mundisla Jolla$3.3M
- Paul SlosarDaly City$3.1M
- Babak Barcohanavan Nuys$2.9M
- Neelakantan AnandLos Angeles$2.9M
- Sanjay KhuranaMarina del Rey$2.3M
- Neville AlleyneOceanside$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.